Cowley J A, Gorman B M
Queensland Institute of Medical Research, Brisbane, Australia.
Vet Microbiol. 1989 Jan;19(1):37-51. doi: 10.1016/0378-1135(89)90089-8.
Genetic reassortment studies of bluetongue virus (BTV) Types 20 and 21 have revealed a reassortant genotype that was not neutralized serotype-specifically. In reciprocal neutralization tests, BTV 20 and 21 were neutralized specifically by homologous antiserum. Similarly, reassortants that possessed both outer capsid proteins (i.e., VP2 and VP5) from the same parent virus reacted with that antiserum specifically. However, two reassortants, 16(9) and 19(1), with VP2 of BTV 20 and VP5 of BTV 21 had intermediate neutralization characteristics. These reassortants were neutralized to high titres by antiserum to BTV 20 and to lower, but significant titres by antiserum to BTV 21. In addition, antiserum to BTV 20 induced 10-16-fold higher titres in plaque reduction neutralization (PRN) tests with these two reassortants compared with BTV 20 itself. Evidence of the serological cross-reactivity of Reassortants 16(9) and 19(1) was also found with respect to reductions in plaque sizes observed in the PRN tests. The average plaque sizes of these reassortants were reduced to differing extents by antiserum to BTV 20 and 21, while those formed by the parent viruses were reduced in size by homologous antiserum only. Immunoblotting analysis of the structural proteins of BTV 20 and 21 demonstrated that VP2 alone was antigenically distinct, therefore confirming its role in determining serotype specificity in virus-neutralization tests. Electrophoretic analysis revealed considerable migrational differences between VP2 and VP5 of the parent viruses, suggesting that there was some divergence in their molecular weights, intrinsic charges or structural compositions. Taken together, the data suggest that the intermediate neutralization characteristics of the reassortants that contain VP2 and VP5 from different parent viruses are due to conformational alterations in their outer capsid structure which allow antibody recognition of common neutralizing epitopes that are not exposed on BTV 20 or BTV 21.
对蓝舌病病毒(BTV)20型和21型的基因重配研究揭示了一种未被血清型特异性中和的重配基因型。在双向中和试验中,BTV 20和21分别被同源抗血清特异性中和。同样,拥有来自同一亲本病毒的两种外衣壳蛋白(即VP2和VP5)的重配体与该抗血清发生特异性反应。然而,两种重配体16(9)和19(1),具有BTV 20的VP2和BTV 21的VP5,具有中间中和特性。这些重配体被抗BTV 20血清中和至高效价,而被抗BTV 21血清中和至较低但显著的效价。此外,与BTV 20本身相比,在对这两种重配体进行蚀斑减少中和(PRN)试验时,抗BTV 20血清诱导的效价高10 - 16倍。在PRN试验中观察到蚀斑大小减小方面,也发现了重配体16(9)和19(1)血清学交叉反应的证据。这些重配体的平均蚀斑大小被抗BTV 20和21血清不同程度地减小,而亲本病毒形成的蚀斑大小仅被同源抗血清减小。对BTV 20和21结构蛋白的免疫印迹分析表明,仅VP2在抗原性上不同,因此证实了其在病毒中和试验中决定血清型特异性的作用。电泳分析揭示了亲本病毒的VP2和VP5之间存在相当大的迁移差异,表明它们在分子量、固有电荷或结构组成上存在一些差异。综上所述,数据表明,含有来自不同亲本病毒的VP2和VP5的重配体的中间中和特性是由于其外衣壳结构的构象改变,这使得抗体能够识别在BTV 20或BTV 21上未暴露的共同中和表位。